Press Releases
Trilliant Health | April 23, 2025Trilliant Health's Chief Research Officer Appointed To Serve in the U.S. Food and Drug Administration (FDA)
BRENTWOOD, TN – April 23, 2025 – Trilliant Health today announced that its Chief Research Officer, Sanjula Jain-Nagpal, Ph.D., has been appointed to serve as the Associate Director of Policy and Research Strategy in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA).
At Trilliant Health, Dr. Jain-Nagpal led the company’s research division and, notably, established the Trends Shaping the Health Economy report, a fact-based national analysis that has become essential reading for leaders across the healthcare industry.
"Dr. Jain-Nagpal’s appointment reflects her exceptional expertise,” said Hal Andrews, Chief Executive Officer of Trilliant Health. “America—and Americans—cannot afford our healthcare system. Our noble purpose has always been to make it exponentially better by enabling stakeholders to deliver more value for money. I have no doubt that Sanjula will take this purpose with her.”
About Trilliant Health
Trilliant Health combines healthcare industry expertise, market research and predictive analytics to form Evidence-Based Strategy for Healthcare™. Trilliant Health's proprietary analytics platform produces a comprehensive understanding of local market dynamics providing exponentially better data insights to maximize returns from growth strategies.
- Press Release